Close Asset Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Close Asset Management’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	–	–	203
2022 Q2	$0	Sell	100 -7,800	-99%	-$7.06K	﹤0.01%	225
2022 Q1	$19K	Hold	7,900	–	–	﹤0.01%	170
2021 Q4	$19K	Hold	7,900	–	–	﹤0.01%	170
2021 Q3	$43K	Buy	+7,900	New	+$49K	﹤0.01%	136

Close Asset Management's KLDO Position: Q3 2022 in Review

Close Asset Management sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q3 2022, closing a stake of 100 shares.

Close Asset Management first reported a position in KLDO in Q3 2021 and held it in 4 quarters. The position peaked at $43K in Q3 2021. 0 funds tracked by Wall St. Rank hold KLDO as of Q3 2022.

Close Asset Management reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Close Asset Management sold 100 Kaleido Biosciences, Inc. Common Stock shares in Q3 2022.
Close Asset Management first reported a position in Kaleido Biosciences, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Close Asset Management's Kaleido Biosciences, Inc. Common Stock position peaked at $43K in Q3 2021.
0 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q3 2022.

Based on Close Asset Management's 13F filing for Q3 2022, filed 26 Oct 2022.